Stay updated on Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This change does not modify the study information or page functionality.
    Difference
    0.0%
    Check dated 2026-03-21T20:23:12.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3; no substantive content changes are evident on the page.
    Difference
    0.0%
    Check dated 2026-03-07T12:50:54.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.4.2, replacing the prior v3.4.1; this is a minor metadata update that does not affect trial information.
    Difference
    0.0%
    Check dated 2026-02-13T17:35:48.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1, a minor system update with no visible changes to study details or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:38:25.000Z thumbnail image
  8. Check
    60 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1 on the page, indicating a system update with no observed changes to the study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T12:41:03.000Z thumbnail image
  9. Check
    67 days ago
    Change Detected
    Summary
    Minor UI/metadata updates include Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, with no impact on study content, eligibility, or results; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-29T07:32:33.000Z thumbnail image

Stay in the know with updates to Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.